Together, these two pathways serve to upregulate a host of pro-inflammatory transcription factors, namely nuclear factor-κB (NF-κB), signal transducer and activator of transcription 3 (STAT3) and hypoxia-inducible factor 1α (HIF1α) in cancer cells [6]. The gene discussed is STAT3; the disease is cancer.